DERIVATIVE FINANCIAL INSTRUMENTS (Tables)

6 Months Ended

Aug. 02, 2020

Derivative Financial Instruments [Abstract]

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]

The following table summarizes the fair value and presentation of the Company’s derivative financial instruments in its Consolidated Balance Sheets:

(In millions)	Assets												Liabilities
	8/2/20				2/2/20				8/4/19				8/2/20				2/2/20				8/4/19
	Other Current Assets		Other Assets		Other Current Assets		Other Assets		Other Current Assets		Other Assets		Accrued Expenses		Other Liabilities		Accrued Expenses		Other Liabilities		Accrued Expenses		Other Liabilities
Contracts designated as cash flow hedges:
Foreign currency forward exchange contracts (inventory purchases)	$	3.0	$	—	$	21.4	$	0.4	$	36.0	$	0.7	$	23.4	$	0.2	$	1.2	$	0.1	$	1.6	$	0.1
Interest rate swap agreements	—		—		0.1		—		0.3		—		8.3		2.9		5.5		0.4		4.1		2.9
Total contracts designated as cash flow hedges	3.0		—		21.5		0.4		36.3		0.7		31.7		3.1		6.7		0.5		5.7		3.0
Undesignated contracts:
Foreign currency forward exchange contracts	2.8		—		1.5		—		3.8		—		6.4		—		0.9		—		2.2		—
Total	$	5.8	$	—	$	23.0	$	0.4	$	40.1	$	0.7	$	38.1	$	3.1	$	7.6	$	0.5	$	7.9	$	3.0

Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance [Table Text Block]

The following tables summarize the effect of the Company’s hedges designated as cash flow and net investment hedging instruments:

	(Loss) Gain Recognized in Other Comprehensive Income (Loss)
(In millions)
Thirteen Weeks Ended	8/2/20		8/4/19
Foreign currency forward exchange contracts  (inventory purchases)	$	(57.9)	$	12.4
Interest rate swap agreements	(0.6)		(4.0)
Foreign currency borrowings (net investment hedges)	(108.1)		4.6
Total	$	(166.6)	$	13.0
Twenty-Six Weeks Ended	8/2/20		8/4/19
Foreign currency forward exchange contracts  (inventory purchases)	$	(36.1)	$	42.5
Interest rate swap agreements	(10.0)		(5.1)
Foreign currency borrowings (net investment hedges)	(92.9)		34.2
Total	$	(139.0)	$	71.6

	Amount of Gain (Loss) Reclassified from AOCL into Income (Expense), Consolidated Statements of Operations Location, and Total Amount of Consolidated Statements of Operations Line Item
(In millions)	Amount Reclassified				Location	Total Statements of Operations Amount
Thirteen Weeks Ended	8/2/20		8/4/19			8/2/20		8/4/19
Foreign currency forward exchange contracts (inventory purchases)	$	0.9	$	10.7	Cost of goods sold	$	697.4	$	1,075.8
Interest rate swap agreements	(2.9)		0.0		Interest expense	32.7		28.3
Total	$	(2.0)	$	10.7
Twenty-Six Weeks Ended	8/2/20		8/4/19			8/2/20		8/4/19
Foreign currency forward exchange contracts (inventory purchases)	$	3.1	$	25.7	Cost of goods sold	$	1,375.5	$	2,136.2
Interest rate swap agreements	(4.6)		0.2		Interest expense	55.2		59.3
Total	$	(1.5)	$	25.9

Derivatives Not Designated as Hedging Instruments [Table Text Block]

The following table summarizes the effect of the Company’s undesignated contracts recognized in SG&A expenses in its Consolidated Statements of Operations:

(In millions)	(Loss) Gain Recognized in (Expense) Income
Thirteen Weeks Ended	8/2/20		8/4/19
Foreign currency forward exchange contracts	$	(4.7)	$	0.8
Twenty-Six Weeks Ended	8/2/20		8/4/19
Foreign currency forward exchange contracts	$	(4.1)	$	0.7